At the same time, the document stated that “crystallisation of sugar reduces the sugar concentration in the remaining liquid, which may theoretically lead to microbiological contamination.” The GIF indicated a real risk of loss of batch quality, especially after first opening the bottle. Potential effects: possible microbiological contamination of the syrup, risk of infection and lack of safe use.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use DEXAPINI syrup from batch 02092024, check the batch number on the package and return the product to the pharmacy; if it has been used and any worrying symptoms occur, contact a doctor.
Distribution of the medicinal product DEXAPINI syrup, batch 02092024, was suspended throughout the country and the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related